Evidence supporting the use of: Ethyl Linoleate
For the health condition: Psoriasis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ethyl linoleate, an ester derivative of linoleic acid (an omega-6 polyunsaturated fatty acid), has some scientific backing for its potential in supporting or treating psoriasis, though the evidence is limited and primarily preclinical. Linoleic acid and its derivatives are known for their anti-inflammatory properties and their role in maintaining skin barrier integrity. In animal models and in vitro studies, ethyl linoleate has demonstrated the capacity to reduce inflammation and modulate immune responses, which are key contributors to psoriasis pathogenesis. One study (Kim et al., 2008) reported that topical ethyl linoleate significantly inhibited the expression of inflammatory markers in a mouse model of psoriasis-like skin inflammation. Additionally, linoleic acid esters have been shown to improve skin hydration and barrier function, which may be beneficial for psoriatic lesions characterized by dryness and scaling. However, clinical evidence directly supporting the use of ethyl linoleate in human psoriasis patients is lacking. Most available studies are preclinical, and there are no large-scale, peer-reviewed clinical trials confirming efficacy in humans. Therefore, while the underlying mechanisms and preliminary data suggest potential benefit, the overall evidence remains modest, and further research is necessary to establish its therapeutic value for psoriasis.

More about Ethyl Linoleate
More about Psoriasis

Other health conditions supported by Ethyl Linoleate

Acne
Dermatitis
Eczema
Psoriasis

Products containing Ethyl Linoleate

We currently have no products on Vitabase that contain this ingredient.